Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2025-12-25 @ 7:55 PM
Study NCT ID:
NCT06722235
Status:
RECRUITING
Last Update Posted:
2025-12-18
First Post:
2024-12-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Sponsor:
Takeda
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Immune Thrombocytopenic Purpura (ITP) | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Thrombocytopenia | View |
| None | TAK-079 | View |
| None | Blood Platelet Disorders | View |
| None | Hematologic Diseases | View |
| None | Cytopenia | View |
| None | Purpura | View |
| None | Hemorrhagic Disorders | View |
| None | Autoimmune Diseases | View |
| None | Immune System Diseases | View |
| None | Hemorrhage | View |
| None | Skin Manifestations | View |
| None | Purpura, Thrombocytopenic, Idiopathic | View |
| None | Purpura, Thrombocytopenic | View |